Arch Grants

SXSW has unveiled their 2025 Pitch competition finalists. Guess who's going.... Congrats We Hear You, Inc! Pierre Paul | Bethanie Couri, MBA | Jamal Stevenson | #STLMade | #2023Cohort https://lnkd.in/gETSd4t5

How is Intramotev's TugVolt technology disrupting an entire industry? #2021Cohort https://lnkd.in/gm3Gyexh

Our January blog is now live! Being recognized as one of only 20 Arch Grants Winners for 2024 is no small feat. For StepStuds Owner and Inventor Michael Cox, this honor signifies much more than an award; it’s a validation of years of hard work, innovation, and dedication. Read more:

When national pharmacy chains began closing their doors, Marcus Howard, Ph.D. saw an opportunity to serve his community. His venture, GreaterHealth Pharmacy & Wellness, ensures residents maintain access to vital medications while providing culturally responsive care and medically tailored solutions. #2023Cohort | #STLMade https://lnkd.in/dut2tVQH

Geneoscopy is honored to have our CEO, Andrew Barnell, share a company update and discuss our mission to transform GI health at the 43rd Annual J.P. Morgan Healthcare Conference! #JPMorganHealthcare #ColoSense #HealthInnovation #HealthcareLeadership #JPM2025

Learn more about #2022Cohort company HabiTerre and agriculture's role in climate change. https://lnkd.in/dWFpD395

We are excited to announce our three 2024 Growth Grants award recipients! Our Growth Grants program is open to companies that we've previously awarded and are positioned to take their businesses to the next stage of growth. The funds awarded through Growth Grants are non-dilutive and awardees must raise matching growth capital from other external sources. Here are your 2024 Growth Grants recipients! Figozo, an Arch Grants 2022 Cohort company, revolutionizes customer experiences across the food, beauty, health, and wellness industries. Through its AI-powered customer experience platform that serves as an automated concierge, they are delivering personalized services and enhancing customer retention. By merging advanced AI with expert human insights, Figozo enables businesses of all sizes to offer premium, tailored customer engagement at scale, boosting satisfaction, loyalty, and revenue without needing in-house technical resources. Company leadership includes Shani Bennett, CEO, and Kevonne Martin, COO. King of the Curve (KOTC) is part of our 2023 Cohort. The company is revolutionizing the journey from high school to physician by offering a comprehensive platform tailored for aspiring medical professionals. Their unique blend of high-quality test prep, personalized mentorship, and cutting-edge predictive analytics ensures students are not only prepared for medical entrance exams but also receive insights into top-tier medical school admissions. While their core expertise is in medical education, the adaptability of their platform means they’re poised to expand their transformational approach to other academic domains in the future. Leadership includes Heath Rutledge-Jukes, Co-Founder, and William Kelly, Co-Founder. iSite Media, Inc., part of our 2019 Cohort, provides brands a platform that showcases a clear message to a captive and targeted audience, while delivering an asset to venues that monetizes an often-overlooked area of their establishment. Fans and visitors routinely visit the restrooms of live sports and entertainment venues, and the company saw this as an opportunity to revolutionize the space with cutting-edge technology that drives new value to advertisers and venues alike. Leadership includes Brian Lord, CEO and Co-Founder, and Kim Lord, Managing Partner and Co-Founder. LEARN MORE: https://lnkd.in/e-9CuKDF

Great coverage of #2024Cohort company Bold Spoon Creamery courtesy of Sauce Magazine. One highlight: yes, we do fund food and beverage startups. As Founder Rachel Burns said in the article, “If you have a vision for growth and innovation, there’s a place for you” at Arch Grants. https://lnkd.in/dZDpyqdP

We love this so much! Keep going, Geneoscopy. #STLMade | Andrew Barnell Erica Barnell | #ChampionTheBold

ICYMI: Geneoscopy closes $105M Series C funding round. #2016Cohort | St. Louis Business Journal https://lnkd.in/esBJDEhu